What is it about?
We employed biased molecular dynamics simulations to investigate the permeation of cisplatin alongside three representative platinum(IV) derivatives across a lipid membrane model representative of human breast cancer cells. By analyzing and comparing their passive diffusion profiles, this study aims to identify the molecular factors that facilitate, or hinder, membrane penetration. Understanding these processes is essential for clarifying how platinum drugs reach their intracellular targets and may ultimately help guide the design of more effective and better-controlled platinum-based anticancer therapies.
Featured Image
Photo by CDC on Unsplash
Why is it important?
Platinum-based drugs remain among the most effective chemotherapeutic agents, yet their clinical success is tempered by significant limitations. Classical platinum(II) compounds, such as cisplatin, are widely used in cancer therapy but often suffer from severe side effects and the frequent emergence of drug resistance. These challenges have motivated an intense search for improved platinum-based strategies, and in this context platinum(IV) complexes have long been regarded as a promising next generation of anticancer agents. From a chemical standpoint, platinum(IV) complexes possess an octahedral geometry and higher kinetic stability compared with their square-planar platinum(II) counterparts. This increased inertness makes them attractive as prodrugs, designed to remain relatively inactive during circulation and become activated only after entering the reducing environment of cancer cells. Upon intracellular reduction, platinum(IV) species release axial ligands together with the active platinum(II) fragment. By carefully selecting these axial groups, it becomes possible to modulate both pharmacological properties and biological activity, potentially creating multifunctional drugs that combine DNA binding with additional therapeutic effects.
Perspectives
In this context, comparing the behavior of four-coordinate platinum(II) complexes with that of six-coordinate platinum(IV) derivatives as they interact with and traverse biological membranes becomes highly relevant. Differences in geometry, polarity, and ligand environment may substantially influence how these compounds partition into the lipid bilayer and migrate across it. To explore this fundamental aspect, we investigated the permeation of cisplatin and three simple platinum(IV) derivatives across a lipid bilayer model representative of human breast cancer cell membranes using biased molecular dynamics simulations. By directly comparing the passive diffusion behavior of Pt(II) and Pt(IV) complexes, this work seeks to uncover the molecular factors that promote or hinder membrane penetration. More broadly, understanding how metal-based drugs navigate biological membranes may provide essential guidelines for the rational design of future platinum therapeutics, helping to bridge the gap between promising chemical concepts and clinically successful anticancer agents.
Dr Costantino Zazza
Universita degli Studi della Tuscia
Read the Original
This page is a summary of: Molecular Dynamics Simulation of Passive Diffusion across a Human Breast Cancer Cell Membrane Model. Comparison between Cisplatin and Its Pt(IV) Derivatives, Journal of Chemical Information and Modeling, March 2026, American Chemical Society (ACS),
DOI: 10.1021/acs.jcim.5c02819.
You can read the full text:
Contributors
The following have contributed to this page
